NCT02274090View on ClinicalTrials.gov

1% Metformin in Moderate and Severe Periodontitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Periodontitis
Interventions
DRUG

Placebo gel

Placebo gel consist of drug without the active component.

DRUG

1% Metformin gel

Metformin gel consist of active component.

All Listed Sponsors
lead

Government Dental College and Research Institute, Bangalore

OTHER

NCT02274090 - 1% Metformin in Moderate and Severe Periodontitis | Biotech Hunter | Biotech Hunter